CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS

被引：0
|
作者：
Vallin, Melanie [1 ]
Guillaud, Olivier [1 ]
Morard, Isabelle [2 ]
Gagnieu, Marie-Claude [1 ]
Mentha, Gilles [2 ]
Adham, Mustapha [1 ]
Morelon, Emmanuel [1 ]
Giostra, Emile [2 ]
Boillot, Olivier [1 ]
Dumortier, Jerome [1 ]
机构：
[1] Hop Edouard Herriot, Liver Transplant Unit, Lyon, France
[2] Hop Cantonal Univ Geneva, Liver Transplant Unit, Geneva, Switzerland
来源：
TRANSPLANT INTERNATIONAL | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [41] INFLUENCE OF IMMUNOSUPPRESSION ON CONVERSION OF CYTOMEGALOVIRUS INFECTION TO DISEASE IN LIVER TRANSPLANT PATIENTS
    Rabbani, Amirhassan
    Mansourian, Mohsenreza
    Moradi, Ali Mohammad
    Kazemi, Koroush
    Nikeghbalian, Saman
    Khosravi, Bahareh
    Hosseini, Sayed Ali Malek
    TRANSPLANT INTERNATIONAL, 2017, 30 : 488 - 488
  • [42] Conversion from Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: Preliminary Results of a 1-Year Study
    Turan, Ilker
    Yapali, Suna
    Karasu, Zeki
    Sozbilen, Murat
    Akarca, Ulus S.
    Ersoz, Galip
    Ozutemiz, Omer
    Gunsar, Fulya
    HEPATOLOGY, 2015, 62 : 826A - 826A
  • [43] Certican® (everolimus) in maintenance heart transplant patients
    Valantine, H
    Zuckermann, A
    Hummel, M
    Lehmkuhl, H
    Epailly, E
    Fiane, A
    Frigerio, M
    Manito, N
    Perrone, S
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (04): : S210 - S210
  • [44] The Efficacy of Everolimus in Liver Transplant Patients
    Sreedhar, S.
    Lu, M.
    Moonka, D.
    Jafri, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S855 - S855
  • [45] EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS
    Meyer, S.
    Deuse, T.
    Baholli, L.
    Sattinger, E.
    Schlueter, M.
    von Stritzky, A.
    Reichenspurner, H.
    Costard-Jaeckle, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 46 - 47
  • [46] Cyclosporine dose reduction in maintenance heart transplant patients following conversion from MMF/azathioprine to everolimus: Results at 12 months.
    Ross, H.
    Burton, J.
    Pflugfelder, P.
    Haddad, H.
    Cantarovich, M.
    White, M.
    Ignaszewski, A.
    Howlett, J.
    Dorent, R.
    Sips, C.
    Vaillancourt, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 445 - 445
  • [47] Potencial Antifbibrotic Effect of Long-Term Everolimus Based Immunosuppression in HCV Positive Liver Transplant Patients
    Dopazo, C.
    Bilbao, I.
    Castells, L.
    Sapisochin, G.
    Campos, I.
    Lazaro, J. L.
    Caralt, M.
    Charco, R.
    TRANSPLANTATION, 2012, 94 (10) : 48 - 48
  • [48] CONVERSION TO EVEROLIMUS IN PEDIATRIC HEART TRANSPLANT PATIENTS
    Castleberry, C.
    Taylor, B.
    Hohlbein, A.
    Jefferies, J.
    Lorts, A.
    Chin, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 67 - 67
  • [49] Everolimus-based immunosuppression in de novo heart transplant recipients:: Impact on wound healing and tissue regeneration
    Zuckermann, Andreas
    Arizon, Jose
    Wang, Shoei-Sheng
    Vigano, Mario
    Maccherini, Massimo
    Vermes, Emmanuelle
    Bara, Christoph
    Ross, Heather
    Laufer, Guenther
    Lehmkuhl, Hans
    Keogh, Anne M.
    Sips, Carole D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 571 - 571
  • [50] EVEROLIMUS AS THE ONLY COMPONENT OF LONG-TERM MAINTENANCE IMMUNOSUPPRESSION AT LIVER TRANSPLANT RECIPIENTS
    Salienko, Anastasia
    Syutkin, Vladimir E.
    Novruzbekov, Murad
    HEPATOLOGY, 2021, 74 : 877A - 878A
12345